Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease
M. Garseth et al., Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease, J NEUROSC R, 60(6), 2000, pp. 779-782
Metabolite levels in cerebrospinal fluid from patients with Parkinson disea
se or Huntington chorea were compared with the levels in healthy controls u
sing proton magnetic resonance spectroscopy. No significant differences wer
e found for any metabolite measured in cerebrospinal fluid from patients wi
th Parkinson disease compared to controls. Slight but significantly reduced
levels of both lactate and citrate, however, were found in cerebrospinal f
luid from patients with Huntington chorea compared to controls. This sugges
ts possible impairment of both glycolysis and tricarboxylic acid cycle func
tion. The reduction in lactate found in the present study may reflect neuro
nal loss. The decrease in citrate supports the theory of mitochondrial dysf
unction in the brain of patients with Huntington chorea, but also suggests
that there may be an important astrocytic component in this disease. If so,
it would certainly have implications for neuronal function. J. Neurosci. R
es. 60: 779-782, 2000. (C) 2000 Wiley-Liss, Inc.